首頁 > 市場調查報告書 > 醫療設備

牛市場規模、佔有率及成長分析（按最終用戶、類型及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1897562

牛市場規模、佔有率及成長分析（按最終用戶、類型及地區分類）－2026-2033年產業預測

Fetal Bovine Serum Market Size, Share, and Growth Analysis, By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs)Vaccine Production), By Type (Serum-free Media, CHO Media), By Region -Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球牛市場規模將達到 7.9227 億美元，到 2025 年將達到 8.4694 億美元，到 2033 年將達到 14.4435 億美元，預測期（2026-2033 年）的複合年成長率為 6.9%。

市場分析預測，牛的需求將顯著成長，主要原因是細胞和生物製藥研究領域的投資不斷增加。細胞培養技術的創新和人們對再生醫學日益成長的興趣是推動這一成長的關鍵因素。此外，慢性病盛行率的上升和細胞療法需求的增加也為牛產業的公司帶來了巨大的機會。然而，供應鏈限制、替代產品的可取得性以及血清批次間的差異等挑戰可能會阻礙市場滲透。此外，在不斷變化的環境中，與動物試驗相關的倫理問題預計將成為牛公司面臨的一大障礙。

全球牛市場促進因素

單株抗體、疫苗和細胞療法在多種疾病治療中的應用日益廣泛，推動了全球生物製藥研發需求的成長。牛作為細胞培養基的補充，在生物製藥生產中發揮至關重要的作用。這項重要功能不僅促進了治療方案的進步，也使牛成為市場成長的關鍵催化劑。隨著研究人員不斷探索和開發創新治療方法，他們對高品質牛的依賴預計將進一步推動其市場擴張和重要性提升。

全球牛市場面臨的限制因素

由於使用牛胎兒採集胎牛血清的過程引發了倫理方面的擔憂，全球牛市場面臨嚴峻的限制。許多動物福利組織對此類做法提出反對，導致公眾對此的關注度不斷提高。隨著公眾動物權利意識的增強，越來越多的個人和倡導團體開始公開反對使用動物進行醫療程序。這種不斷變化的倫理環境給市場帶來了挑戰，並可能限制其成長，因為牛的替代品正在逐漸普及，生物技術和製藥業對更人道做法的需求也在不斷成長。

全球牛市場趨勢

隨著生物醫學研究和藥物開發領域對3D細胞培養技術的日益廣泛應用，全球牛市場正經歷顯著成長。這項創新技術正在革新傳統的細胞培養方法，從而催生了對高品質牛的需求，而胎牛血清對於維持3D細胞模型所需的複雜環境至關重要。研究人員日益重視研究的有效性和可靠性，牛在增強這些複雜系統的穩定性和活力方面發揮關鍵作用，使其成為不可或缺的組成部分。因此，市場相關人員正蓄勢待發，準備把握這一趨勢，最終推動收入成長，並促進細胞治療方法的發展。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific（USA）
Merck KGaA（Germany）
Danaher Corporation（USA）
Corning Inc.（USA）
Bio-Techne Corporation（USA）
HiMedia Laboratories（India）
PAN-Biotech（Germany）
Bovogen Biologicals Pty Ltd（Australia）
Atlanta Biologicals Inc.（USA）
TCS Biosciences Ltd（UK）
Rocky Mountain Biologicals（RMBIO）（USA）
Biowest（Sera Scandia A/S）（France）
ZenBio, Inc.（USA）
Gemini Bio-Products（USA）
Atlas Biologicals, Inc.（USA）
Moregate Biotech（Australia）
SeraCare Life Sciences（USA）
Access Biologicals（USA）
Biological Industries（Israel）
Wisent Bioproducts（Canada）

結論與建議

簡介目錄

Product Code: SQMIG35I2208

Global Fetal Bovine Serum Market size was valued at USD 792.27 Million in 2024 and is poised to grow from USD 846.94 Million in 2025 to USD 1444.35 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

Market insights indicate that the demand for fetal bovine serum is set to increase significantly, primarily driven by enhanced investments in cell and biopharmaceutical research. Innovations in cell culture technologies and a rising interest in regenerative medicine are key contributors to this growth. Additionally, the escalating prevalence of chronic diseases and the increasing need for cell therapies present substantial opportunities for companies in the fetal bovine serum sector. However, challenges such as supply chain limitations, the availability of alternative products, and variations in serum batches may hinder market adoption. Furthermore, ethical concerns surrounding animal testing are anticipated to emerge as significant obstacles for fetal bovine serum firms in the evolving landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fetal Bovine Serum market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fetal Bovine Serum Market Segments Analysis

Global Fetal Bovine Serum Market is segmented by Types, Application, End-User and region. Based on Types, the market is segmented into Charcoal Stripped, Stem Cells, Dialyzed, Inactivated and Others. Based on Application, the market is segmented into Drug Discovery, Cell Culture, Immunoassay and Others. Based on End-User, the market is segmented into Research And Academic Institutions, Diagnostics Labs, Pharmaceuticals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fetal Bovine Serum Market

The increasing application of monoclonal antibodies, vaccines, and cell therapies in treating numerous medical conditions has led to a heightened demand for biopharmaceutical research on a global scale. Fetal bovine serum plays a crucial role as a supplement in cell culture media essential for biopharmaceutical production. This vital function not only supports advancements in therapeutic solutions but also positions fetal bovine serum as a significant catalyst for growth within the market. As researchers continue to explore and develop innovative treatments, the reliance on quality fetal bovine serum is expected to further contribute to its market expansion and prominence.

Restraints in the Global Fetal Bovine Serum Market

The global fetal bovine serum market faces significant restraints due to ethical concerns surrounding the collection process, which involves the use of bovine fetuses. Many animal welfare organizations have expressed objections to these practices, leading to increasing public scrutiny. As societal awareness of animal rights grows, a rising number of individuals and advocacy groups are voicing their disapproval of medical procedures that involve the use of animals. This evolving ethical landscape poses challenges for the market, potentially restricting its growth as alternatives to fetal bovine serum gain favor and pressure mounts for more humane practices within the biotechnological and pharmaceutical sectors.

Market Trends of the Global Fetal Bovine Serum Market

The global fetal bovine serum market is experiencing significant growth, driven by the increasing adoption of 3D cell culture technologies across biomedical research and pharmaceutical development. This innovative approach is transforming traditional cell culture methods, creating demand for high-quality fetal bovine serum, which is essential for sustaining the intricate environments required for 3D cellular models. As researchers prioritize efficacy and reliability in their studies, fetal bovine serum's role in enhancing the stability and viability of these complex systems positions it as a critical component. Consequently, market players are poised to leverage this trend, ultimately driving revenue and fostering advancements in cell-based therapies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis

Global Fetal Bovine Serum Market Size by Types & CAGR (2026-2033)

Market Overview
Charcoal Stripped
Stem Cells
Dialyzed
Inactivated
Others

Global Fetal Bovine Serum Market Size by Application & CAGR (2026-2033)

Market Overview
Drug Discovery
Cell Culture
Immunoassay
Others

Global Fetal Bovine Serum Market Size by End-User & CAGR (2026-2033)

Market Overview
Research And Academic Institutions
Diagnostics Labs
Pharmaceuticals
Others

Global Fetal Bovine Serum Market Size & CAGR (2026-2033)

North America (Types, Application, End-User)
- US
- Canada
Europe (Types, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Types, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Types, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Types, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HiMedia Laboratories (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PAN-Biotech (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bovogen Biologicals Pty Ltd (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atlanta Biologicals Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TCS Biosciences Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rocky Mountain Biologicals (RMBIO) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biowest (Sera Scandia A/S) (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZenBio, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gemini Bio-Products (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atlas Biologicals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moregate Biotech (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SeraCare Life Sciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Access Biologicals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological Industries (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wisent Bioproducts (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments